Age-period-cohort analysis of the global burden of visual impairment according to major causes: an analysis of the Global Burden of Disease Study 2019.
Chen Jianqi, Zhu Yingting, Li Zhidong, Zhuo Xiaohua, Zhang Shaochong, Zhuo Yehong
AI Summary
This study analyzed global visual impairment trends from cataract, glaucoma, and AMD. Glaucoma/AMD prevalence declined globally, but cataract rose. Heterogeneity across regions highlights varied vision health and treatment priorities.
Abstract
Background
Cataract, glaucoma and age-related macular degeneration (AMD) are major causes of visual impairment. As these are age-related conditions, the prevalence of associated visual impairment is anticipated to increase as the population ages. However, age-period-cohort effects on the disease burden have not been investigated.
Methods
This was a population-based study using aggregated data from the Global Burden of Disease Study 2019. Age-period-cohort analysis was conducted using age-standardised prevalence rates (ASPRs) of visual impairment caused by cataract, glaucoma and AMD as disease burden indicator.
Results
In 2019, the estimated global ASPRs of visual impairment due to cataract, glaucoma and AMD were 1207.9, 94.7 and 96.8 per 100 000 people, respectively. Between 1990 and 2019, the global visual impairment ASPRs for glaucoma and AMD declined by 15.4% and 2.0%, respectively, whereas that for cataract increased by 5.0%. Wide heterogeneity was observed in age-period-cohort effects on ASPRs across different Sociodemographic Index (SDI) regions. Low-middle SDI regions had the largest ASPR reductions for all three eye diseases and showed improvement in both period and cohort effects. In contrast, in high-middle SDI regions, visual impairment ASPRs significantly increased during the study period with unfavourable patterns.
Conclusions
The wide heterogeneity in age-period-cohort effects reflects different stages of societal transition and vision health. The unfavourable trends in age-period-cohort effects on disease prevalence identified in specific groups provide key information that may be used to identify priority groups in need of treatment and prevention.
MeSH Terms
Shields Classification
Key Concepts5
In 2019, the estimated global age-standardised prevalence rates (ASPRs) of visual impairment due to cataract, glaucoma, and age-related macular degeneration (AMD) were 1207.9, 94.7, and 96.8 per 100,000 people, respectively.
Between 1990 and 2019, the global visual impairment age-standardised prevalence rates (ASPRs) for glaucoma and age-related macular degeneration (AMD) declined by 15.4% and 2.0%, respectively, whereas that for cataract increased by 5.0%.
Wide heterogeneity was observed in age-period-cohort effects on age-standardised prevalence rates (ASPRs) of visual impairment across different Sociodemographic Index (SDI) regions for cataract, glaucoma, and age-related macular degeneration (AMD).
Low-middle Sociodemographic Index (SDI) regions had the largest age-standardised prevalence rate (ASPR) reductions for visual impairment due to cataract, glaucoma, and age-related macular degeneration (AMD), and showed improvement in both period and cohort effects.
In high-middle Sociodemographic Index (SDI) regions, visual impairment age-standardised prevalence rates (ASPRs) for cataract, glaucoma, and age-related macular degeneration (AMD) significantly increased during the study period with unfavourable patterns.
Related Articles5
Social determinants of health and health disparities in glaucoma: A review.
ReviewAn assessment of the health and economic burdens of glaucoma.
ReviewGlaucoma report: patients' sight is put at risk by treatment delays.
EditorialSocioeconomic Disparities in Glaucoma Severity at Initial Diagnosis: A Nationwide Electronic Health Record Cohort Analysis.
Cross-Sectional StudyBarriers and Potential Solutions to Glaucoma Screening in the Developing World: A Review.
ReviewIs this article assigned to the wrong chapter(s)? Let us know.